Data were adjusted to deuterated internal standards, then normalised to protein concentration
It was originally developed for the management of type 2 diabetes and later received FDA approval for chronic weight management in adults with obesity or those who are overweight with at least one weight-related health condition
It is designed for FIP treatment in cats weighing under 2.5 kg where secondary systemic complications anaemia, neurological involvement, appetite suppression, or immune compromise are present alongside the primary FIP diagnosis
This good version KLOW formula uses BPC-157 Salt Arginate for a more premium peptide research presentation, paired with GHK-Cu, KPV, and TB-500 for researchers who require clear capsule-strength labeling, cGMP production standards, formula transparency, internal QA review, and direct in-house fulfillment
Because many of the patients we see, day in and day out, they've gone everywhere